ASGARD THERAPEUTICS

asgard-therapeutics-logo

Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen-presenting cells.

#SimilarOrganizations #People #Financial #Website #More

ASGARD THERAPEUTICS

Social Links:

Industry:
Biotechnology Therapeutics

Founded:
2018-01-01

Address:
Lund, Skane Lan, Sweden

Country:
Sweden

Website Url:
http://www.asgardthx.com

Total Employee:
1+

Status:
Active

Total Funding:
36 M EUR

Technology used in webpage:
Euro Gravity Forms Swedish Server Location


Similar Organizations

csavm-union-chamber-of-algae-and-marine-plants-logo

CSAVM - Union Chamber of Algae and Marine Plants

CSAVM - Union Chamber of Algae and Marine Plants is a Biotechnology Company.

cygnal-therapeutics-logo

Cygnal Therapeutics

Cygnal Therapeutics is a biotechnology company

idac-theranostics-logo

IDAC Theranostics

IDAC Theranostics is a Biotechnology Company.

isarna-therapeutics-logo

Isarna Therapeutics

Isarna Therapeutics is a biotechnology company.

neoplants-logo

Neoplants

Neoplants is a Biotechnology Company.

telum-therapeutics-logo

Telum Therapeutics

Telum Therapeutics is a biotechnology company.

tethis-spa-logo

Tethis S.p.A

Tethis is a bio- and nanotechnology company.

xios-therapeutics-logo

Xios Therapeutics

Xios Therapeutics is a biotechnology company .


Current Advisors List

aleksei-zeifman_image

Aleksei Zeifman Board Member @ Asgard Therapeutics
Board_member

jonas-jendi_image

Jonas Jendi Board Member @ Asgard Therapeutics
Board_member
2021-11-01

søren-møller_image

Søren Møller Board Member @ Asgard Therapeutics
Board_member
2021-11-01

philipp-müller_image

Philipp Müller Board Member @ Asgard Therapeutics
Board_member
2021-11-01

joao-ribas_image

Joao Ribas Board Observer @ Asgard Therapeutics
Board_observer
2021-11-01

Current Employees Featured

fábio-rosa_image

Fábio Rosa
Fábio Rosa Co-founder and Head of Research @ Asgard Therapeutics
Co-founder and Head of Research

filipe-pereira_image

Filipe Pereira
Filipe Pereira Co-founder, Board Member and Head of Innovation @ Asgard Therapeutics
Co-founder, Board Member and Head of Innovation
2018-12-01

lars-hedbys_image

Lars Hedbys
Lars Hedbys Chairman Of The Board @ Asgard Therapeutics
Chairman Of The Board
2021-01-01

not_available_image

Cristiana Pires
Cristiana Pires Co-Founder and CEO @ Asgard Therapeutics
Co-Founder and CEO

Founder


not_available_image

Cristiana Pires

filipe-pereira_image

Filipe Pereira

fábio-rosa_image

Fábio Rosa

Investors List

rv-invest_image

RV Invest

RV Invest investment in Series A - Asgard Therapeutics

boehringer-ingelheim-venture-fund_image

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund investment in Series A - Asgard Therapeutics

industrifonden_image

Industrifonden

Industrifonden investment in Series A - Asgard Therapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series A - Asgard Therapeutics

johnson-johnson-innovation-jjdc_image

Johnson & Johnson Innovation – JJDC

Johnson & Johnson Innovation – JJDC investment in Series A - Asgard Therapeutics

boehringer-ingelheim-venture-fund_image

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund investment in Seed Round - Asgard Therapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Seed Round - Asgard Therapeutics

industrifonden_image

Industrifonden

Industrifonden investment in Seed Round - Asgard Therapeutics

lu-innovation_image

LU Innovation

LU Innovation investment in Venture Round - Asgard Therapeutics

Official Site Inspections

http://www.asgardthx.com

  • Host name: website-proxy.ilait.se
  • IP address: 185.15.121.100
  • Location: Sweden
  • Latitude: 59.3247
  • Longitude: 18.056
  • Timezone: Europe/Stockholm

Asgardthx.com lookup results from whois.namesrs.com server:
  • Domain created: 5th-Jan-2019
  • Domain updated: 21st-Nov-2024
  • Domain expires: 5th-Jan-2026 0 Years, 357 Days left
  • Website age: 6 Years, 8 Days
  • Registrar Domain ID: 2349840392_DOMAIN_COM-VRSN
  • Registrar Url: http://www.namesrs.com
  • Registrar WHOIS Server: whois.namesrs.com
  • Registrar Abuse Contact Email: abuse@namesrs.com
  • Registrar Abuse Contact Phone: +46.313011220
  • Name server:
    • NS1.ILAIT.SE
    • NS2.ILAIT.SE
    • NS3.ILAIT.SE
    • NS4.ILAIT.SE

More informations about "Asgard Therapeutics"

Asgard Therapeutics - Crunchbase Company Profile

Asgard Therapeutics may be growing as it has successfully secured significant funding in a Series A investment round. The company received $32 million in backing from notable investors including J&J, Novo, and Boehringer, …See details»

Asgard Therapeutics - LinkedIn

Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies.See details»

Asgard Therapeutics selects Exothera to bring their viral vector …

Jun 11, 2024 For more information, please visit: www.asgardthx.com About Exothera SA. Exothera is a contract, development, and manufacturing organization (CDMO) dedicated to …See details»

Eurostars-funded REPRINT consortium reaches milestones with …

Apr 11, 2023 cristiana.pires@asgardthx.com About Asgard Therapeutics ... Antineo is a French private Contract Research Organization specializing in Preclinical Oncology. Antineo …See details»

Asgard Therapeutics AB - Privacy Policy - Asgard Therapeutics

We may also collect your personal data from a third party, usually from the company or organization you represent. 3. How we process your personal data ...See details»

Asgard Therapeutics Company Profile 2024: Valuation, Funding ...

Information on valuation, funding, cap tables, investors, and executives for Asgard Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Asgard Therapeutics - Facebook

Asgard Therapeutics. 91 likes. Spin-off company from the Cell Reprogramming Lab at Lund University focusing on developing cancer immunotherapies based on...See details»

Asgard Therapeutics - VentureRadar

"Asgard Therapeutics is a biotech company that pioneers in vivo direct cell reprogramming for cancer immunotherapy. It aims to develop its lead program AT-108, a first-in-class gene …See details»

Asgard - The Index Project

Asgard Therapeutic’s mission is to pioneer direct cell reprogramming for cancer immunotherapy. Our current focus is to develop scalable reprogramming technologies enabling the direct in …See details»

Asgard Therapeutics - Craft

Asgard Therapeutics has 5 employees at their 1 location. See insights on Asgard Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»

Careers - Asgard Therapeutics

Join us. Asgard Therapeutics is a private biotech company aiming to advance cancer immunotherapies by harnessing direct in-vivo cell fate reprogramming technologies. Formed …See details»

Asgard Therapeutics | BIO-Europe - Informa Connect

Asgard Therapeutics is a private preclinical-stage biotech company pioneering in vivo direct reprogramming for cancer immunotherapy. Since the end of 2021, Asgard is supported by …See details»

Asgard Therapeutics Granted U.S. Patent for Dendritic Cell …

Lund, Sweden – 01 June – Asgard Therapeutics AB (“Asgard”) today announces that the United States Patent and Trademark Office (USPTO) has granted Asgard’s foundational patent …See details»

Asgard Therapeutics Announces Appointment of Three Members …

Lund, Sweden, November 9 th 2022 – Asgard Therapeutics AB (“Asgard”), a private biotech company pioneering in vivo direct reprogramming approaches for cancer immunotherapy, …See details»

Eurostars-funded REPRINT Project Kick-off Meeting - Pereira Lab

For more information: Cristiana Pires, CEO of Asgard Therapeutics, coordinator of the REPRINT project, cristiana.pires@asgardthx.com. In the Photo: In-person kick-off meeting of the …See details»

Asgard Therapeutics Snags €30M to Develop In Vivo Direct Cell ...

LUND, Sweden, March 14, 2024 — Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, announces a €30 …See details»

Asgard Therapeutics selects Exothera to bring their viral vector …

For more information, please visit: www.asgardthx.com. About Exothera SA. Exothera is a contract, development, and manufacturing organization (CDMO) dedicated to viral vector and …See details»

Asgard Therapeutics reaches a major research milestone in the ...

Mar 9, 2022 fabio.rosa@asgardthx.com. About Asgard Therapeutics: Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies …See details»

Asgard Therapeutics Selects Exothera to Bring their Viral Vector …

Jun 12, 2024 For more information, please visit: www.asgardthx.com About Exothera SA Exothera is a contract, development, and manufacturing organization (CDMO) dedicated to …See details»

News - Asgard Therapeutics

Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage. Asgard Therapeutics today announced it selected Exothera S.A. …See details»

linkstock.net © 2022. All rights reserved